{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:19:07Z","timestamp":1787667547541,"version":"build-2736575974"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T00:00:00Z","timestamp":1686182400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T00:00:00Z","timestamp":1686182400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Delta University for Science and Technology"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AMB Expr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Non-alcoholic steatohepatitis (NASH) is a more dangerous form of chronic non-alcoholic fatty liver disease (NAFLD). In the current investigation, the influence of citicoline on high-fat diet (HFD)-induced NASH was examined, both alone and in combination with <jats:italic>Lactobacillus<\/jats:italic> (probiotic). NASH was induced by feeding HFD (10% sugar, 10% lard stearin, 2% cholesterol, and 0.5% cholic acid) to rats for 13 weeks and received single i.p. injection of streptozotocin (STZ, 30\u00a0mg\/kg) after 4 weeks. Citicoline was given at two dose levels (250\u00a0mg and 500\u00a0mg, i.p.) at the beginning of the sixth week, and in combination with an oral suspension of <jats:italic>Lactobacillus<\/jats:italic> every day for eight weeks until the study\u2019s conclusion. HFD\/STZ induced steatohepatitis as shown by histopathological changes, elevated serum liver enzymes, serum hyperlipidemia and hepatic fat accumulation. Moreover, HFD convinced oxidative stress by increased lipid peroxidation marker (MDA) and decreased antioxidant enzymes (GSH and TAC). Upregulation of TLR4\/NF-kB and the downstream inflammatory cascade (TNF-\u03b1, and IL-6) as well as Pentaraxin, fetuin-B and apoptotic markers (caspase-3 and Bax) were observed. NASH rats also had massive increase in <jats:italic>Bacteroides spp., Fusobacterium spp., E. coli, Clostridium spp., Providencia spp., Prevotella interrmedia<\/jats:italic>, and <jats:italic>P. gingivalis<\/jats:italic> while remarkable drop in <jats:italic>Bifidobacteria spp<\/jats:italic>. and <jats:italic>Lactobacillus spp.<\/jats:italic> Co-treatment with citicoline alone and with <jats:italic>Lactobacillus<\/jats:italic> improve histopathological NASH outcomes and reversed all of these molecular pathological alterations linked to NASH via upregulating the expression of Nrf2\/HO-1 and downregulating TLR4\/NF-kB signaling pathways. These results suggest that citicoline and lactobacillus may represent new hepatoprotective strategies against NASH progression.<\/jats:p>","DOI":"10.1186\/s13568-023-01561-8","type":"journal-article","created":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T16:01:39Z","timestamp":1686240099000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Valuable effects of lactobacillus and citicoline on steatohepatitis: role of Nrf2\/HO-1 and gut microbiota"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7290-6907","authenticated-orcid":false,"given":"Ahmed M.","family":"El-Baz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira M.","family":"El-Ganiny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doaa","family":"Hellal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hala M.","family":"Anwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hend A. Abd","family":"El-Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim E.","family":"Tharwat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"El-Adawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shehab El-Din M.","family":"Helal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menna Tallah A.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tassnim M.","family":"Azb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanya M.","family":"Elshafaey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AbdulRahman A.","family":"Shalata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar M.","family":"Elmeligi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noran H.","family":"Abdelbary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attalla F.","family":"El-kott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatimah A.","family":"Al-Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman T.","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed M. Adel","family":"El-Sokkary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Shata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed A.","family":"Shabaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,8]]},"reference":[{"key":"1561_CR1","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.intimp.2017.05.035","volume":"49","author":"MR Afrin","year":"2017","unstructured":"Afrin MR, Arumugam S, Rahman MA, Karuppagounder V, Harima M, Suzuki H, Miyashita S, Suzuki K, Ueno K, Yoneyama H, Watanabe K (2017) Curcumin reduces the risk of chronic kidney damage in mice with nonalcoholic steatohepatitis by modulating endoplasmic reticulum stress and MAPK signaling. Int Immunopharmacol 49:161\u2013167. https:\/\/doi.org\/10.1016\/j.intimp.2017.05.035","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"1561_CR2","doi-asserted-by":"publisher","first-page":"423","DOI":"10.32598\/bcn.11.4.1097.1","volume":"11","author":"HM Al-Kuraishy","year":"2020","unstructured":"Al-Kuraishy HM, Al-Gareeb AI (2020) Citicoline improves human vigilance and visual Working memory: the role of neuronal activation and oxidative stress. Basic Clin Neurosci 11(4):423\u2013432. https:\/\/doi.org\/10.32598\/bcn.11.4.1097.1","journal-title":"Basic Clin Neurosci"},{"issue":"4","key":"1561_CR4","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1093\/clinchem\/20.4.470","volume":"20","author":"CC Allain","year":"1974","unstructured":"Allain CC, Poon LS, Chan CS, Richmond W, Fu PC (1974) Enzymatic determination of total serum cholesterol. Clin Chem 20(4):470\u2013475","journal-title":"Clin Chem"},{"issue":"9","key":"1561_CR5","first-page":"1090","volume":"15","author":"R Aller","year":"2011","unstructured":"Aller R, De Luis D, Izaola O, Conde R, Gonzalez Sagrado M, Primo D, De La Fuente B, Gonzalez J (2011) Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: a double blind randomized clinical trial. Eur Rev Med Pharmacol Sci 15(9):1090\u20131095","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"1561_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12906-016-1540-z","volume":"17","author":"HM Al-Muzafar","year":"2017","unstructured":"Al-Muzafar HM, Amin KA (2017) Probiotic mixture improves fatty liver disease by virtue of its action on lipid profiles, leptin, and inflammatory biomarkers. BMC Complement Altern Med 17(1):1\u20139","journal-title":"BMC Complement Altern Med"},{"issue":"6","key":"1561_CR6","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1139\/bcb-2018-0218","volume":"97","author":"A Aminzadeh","year":"2019","unstructured":"Aminzadeh A, Salarinejad A (2019) Citicoline protects against lead-induced oxidative injury in neuronal PC12 cells. Biochem Cell Biol 97(6):715\u2013721. https:\/\/doi.org\/10.1139\/bcb-2018-0218","journal-title":"Biochem Cell Biol"},{"key":"1561_CR7","doi-asserted-by":"crossref","unstructured":"Aragon\u00e8s G, Gonz\u00e1lez-Garc\u00eda S, Aguilar C, Richart C, Auguet T (2019) Gut microbiota-derived mediators as potential markers in nonalcoholic fatty liver disease. Biomed Res Int 2019","DOI":"10.1155\/2019\/8507583"},{"issue":"7346","key":"1561_CR8","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/nature09944","volume":"473","author":"M Arumugam","year":"2011","unstructured":"Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, Fernandes GR, Tap J, Bruls T, Batto J-M (2011) Enterotypes of the human gut microbiome. Nature 473(7346):174\u2013180","journal-title":"Nature"},{"key":"1561_CR9","doi-asserted-by":"crossref","unstructured":"Azarang A, Farshad O, Ommati MM, Jamshidzadeh A, Heidari R, Abootalebi SN, Gholami A (2020) Protective role of probiotic supplements in hepatic steatosis: a rat model study. Biomed Res Int 2020","DOI":"10.1155\/2020\/5487659"},{"issue":"6","key":"1561_CR10","doi-asserted-by":"publisher","first-page":"3575","DOI":"10.1128\/AEM.70.6.3575-3581.2004","volume":"70","author":"S Bartosch","year":"2004","unstructured":"Bartosch S, Fite A, Macfarlane GT, McMurdo ME (2004) Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiota. Appl Environ Microbiol 70(6):3575\u20133581","journal-title":"Appl Environ Microbiol"},{"issue":"11","key":"1561_CR11","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.1128\/jcm.33.11.2908-2912.1995","volume":"33","author":"RM Benkirane","year":"1995","unstructured":"Benkirane RM, Guillot E, Mouton C (1995) Immunomagnetic PCR and DNA probe for detection and identification of Porphyromonas gingivalis. J Clin Microbiol 33(11):2908\u20132912","journal-title":"J Clin Microbiol"},{"issue":"9","key":"1561_CR12","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1089\/met.2015.0046","volume":"13","author":"S Boga","year":"2015","unstructured":"Boga S, Koksal AR, Alkim H, Yilmaz Ozguven MB, Bayram M, Ergun M, Sisman G, Tekin Neijmann S, Alkim C (2015) Plasma pentraxin 3 differentiates nonalcoholic steatohepatitis (NASH) from Non-NASH. Metab Syndr Relat Disord 13(9):393\u2013399. https:\/\/doi.org\/10.1089\/met.2015.0046","journal-title":"Metab Syndr Relat Disord"},{"issue":"8","key":"1561_CR13","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.3390\/ijms19082458","volume":"19","author":"P Bogdanov","year":"2018","unstructured":"Bogdanov P, Sampedro J, Sol\u00e0-Adell C, Sim\u00f3-Servat O, Russo C, Varela-Sende L, Sim\u00f3 R, Hern\u00e1ndez C (2018) Effects of Liposomal Formulation of Citicoline in Experimental Diabetes-Induced Retinal Neurodegeneration. Int J Mol Sci 19(8):2458","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1561_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1600-065X.2008.00719.x","volume":"227","author":"B Bottazzi","year":"2009","unstructured":"Bottazzi B, Garlanda C, Cotena A, Moalli F, Jaillon S, Deban L, Mantovani A (2009) The long pentraxin PTX3 as a prototypic humoral pattern recognition receptor: interplay with cellular innate immunity. Immunol Rev 227(1):9\u201318. https:\/\/doi.org\/10.1111\/j.1600-065X.2008.00719.x","journal-title":"Immunol Rev"},{"issue":"3","key":"1561_CR15","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1002\/hep.28356","volume":"63","author":"J Boursier","year":"2016","unstructured":"Boursier J, Mueller O, Barret M, Machado M, Fizanne L, Araujo-Perez F, Guy CD, Seed PC, Rawls JF, David LA (2016) The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota. Hepatology (Baltimore MD) 63(3):764\u2013775","journal-title":"Hepatology (Baltimore MD)"},{"issue":"8","key":"1561_CR16","doi-asserted-by":"publisher","first-page":"727","DOI":"10.3748\/wjg.v18.i8.727","volume":"18","author":"V Braunersreuther","year":"2012","unstructured":"Braunersreuther V, Viviani GL, Mach F, Montecucco F (2012) Role of cytokines and chemokines in non-alcoholic fatty liver disease. World J Gastroenterol 18(8):727","journal-title":"World J Gastroenterol"},{"issue":"5","key":"1561_CR17","first-page":"1399","volume":"22","author":"AL Buchman","year":"1995","unstructured":"Buchman AL, Dubin MD, Moukarzel AA, Jenden DJ, Roch M, Rice KM, Gornbein J, Ament ME (1995) Choline deficiency: a cause of hepatic steatosis during parenteral nutrition that can be reversed with intravenous choline supplementation. Hepatology (Baltimore MD) 22(5):1399\u20131403","journal-title":"Hepatology (Baltimore MD)"},{"issue":"1","key":"1561_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13073-015-0177-8","volume":"7","author":"MB Burns","year":"2015","unstructured":"Burns MB, Lynch J, Starr TK, Knights D, Blekhman R (2015) Virulence genes are a signature of the microbiome in the colorectal tumor microenvironment. Genome Med 7(1):1\u201312","journal-title":"Genome Med"},{"issue":"1","key":"1561_CR19","doi-asserted-by":"publisher","first-page":"e0244763","DOI":"10.1371\/journal.pone.0244763","volume":"16","author":"JK Carter","year":"2021","unstructured":"Carter JK, Bhattacharya D, Borgerding JN, Fiel MI, Faith JJ, Friedman SL (2021) Modeling dysbiosis of human NASH in mice: loss of gut microbiome diversity and overgrowth of Erysipelotrichales. PLoS ONE 16(1):e0244763","journal-title":"PLoS ONE"},{"issue":"2","key":"1561_CR20","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1101\/gr.126516.111","volume":"22","author":"M Castellarin","year":"2012","unstructured":"Castellarin M, Warren RL, Freeman JD, Dreolini L, Krzywinski M, Strauss J, Barnes R, Watson P, Allen-Vercoe E, Moore RA (2012) Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res 22(2):299\u2013306","journal-title":"Genome Res"},{"issue":"2","key":"1561_CR21","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.freeradbiomed.2009.11.007","volume":"48","author":"S Chowdhry","year":"2010","unstructured":"Chowdhry S, Nazmy MH, Meakin PJ, Dinkova-Kostova AT, Walsh SV, Tsujita T, Dillon JF, Ashford ML, Hayes JD (2010) Loss of Nrf2 markedly exacerbates nonalcoholic steatohepatitis. Free Radic Biol Med 48(2):357\u2013371. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2009.11.007","journal-title":"Free Radic Biol Med"},{"issue":"7","key":"1561_CR22","doi-asserted-by":"publisher","first-page":"G483","DOI":"10.1152\/ajpgi.00079.2013","volume":"305","author":"JR Clapper","year":"2013","unstructured":"Clapper JR, Hendricks MD, Gu G, Wittmer C, Dolman CS, Herich J, Athanacio J, Villescaz C, Ghosh SS, Heilig JS, Lowe C, Roth JD (2013) Diet-induced mouse model of fatty liver disease and nonalcoholic steatohepatitis reflecting clinical disease progression and methods of assessment. Am J Physiol Gastrointest Liver Physiol 305(7):G483\u2013G495. https:\/\/doi.org\/10.1152\/ajpgi.00079.2013","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"4","key":"1561_CR23","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1093\/ajcn\/88.4.894","volume":"88","author":"MC Collado","year":"2008","unstructured":"Collado MC, Isolauri E, Laitinen K, Salminen S (2008) Distinct composition of gut microbiota during pregnancy in overweight and normal-weight women. Am J Clin Nutr 88(4):894\u2013899","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"1561_CR24","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/MOG.0b013e32834e7b4b","volume":"28","author":"KD Corbin","year":"2012","unstructured":"Corbin KD, Zeisel SH (2012) Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression. Curr Opin Gastroenterol 28(2):159\u2013165. https:\/\/doi.org\/10.1097\/MOG.0b013e32834e7b4b","journal-title":"Curr Opin Gastroenterol"},{"issue":"1","key":"1561_CR25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4103\/ijmr.IJMR_1456_17","volume":"149","author":"E Dhamija","year":"2019","unstructured":"Dhamija E, Paul SB, Kedia S (2019) Non-alcoholic fatty liver disease associated with hepatocellular carcinoma: an increasing concern. Indian J Med Res 149(1):9","journal-title":"Indian J Med Res"},{"issue":"4","key":"1561_CR26","first-page":"989","volume":"7","author":"RO Ek","year":"2014","unstructured":"Ek RO, Serter M, Ergin K, Cecen S, Unsal C, Yildiz Y, Bilgin MD (2014) Protective effects of citicoline on TNBS-induced experimental colitis in rats. Int J Clin Exp Med 7(4):989\u2013997","journal-title":"Int J Clin Exp Med"},{"key":"1561_CR27","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2147\/cmar.s186696","volume":"11","author":"DS El-Agamy","year":"2019","unstructured":"El-Agamy DS, El-Harbi KM, Khoshhal S, Ahmed N, Elkablawy MA, Shaaban AA, Abo-Haded HM (2019) Pristimerin protects against doxorubicin-induced cardiotoxicity and fibrosis through modulation of Nrf2 and MAPK\/NF-kB signaling pathways. Cancer Manag Res 11:47\u201361. https:\/\/doi.org\/10.2147\/cmar.s186696","journal-title":"Cancer Manag Res"},{"key":"1561_CR28","doi-asserted-by":"publisher","first-page":"117927","DOI":"10.1016\/j.lfs.2020.117927","volume":"256","author":"AM El-Baz","year":"2020","unstructured":"El-Baz AM, Khodir AE, Adel El-Sokkary MM, Shata A (2020) The protective effect of Lactobacillus versus 5-aminosalicylic acid in ulcerative colitis model by modulation of gut microbiota and Nrf2\/Ho-1 pathway. Life Sci 256:117927. https:\/\/doi.org\/10.1016\/j.lfs.2020.117927","journal-title":"Life Sci"},{"key":"1561_CR29","doi-asserted-by":"publisher","first-page":"107757","DOI":"10.1016\/j.intimp.2021.107757","volume":"96","author":"AM El-Baz","year":"2021","unstructured":"El-Baz AM, Shata A, Hassan HM, El-Sokkary MMA, Khodir AE (2021) The therapeutic role of lactobacillus and montelukast in combination with metformin in diabetes mellitus complications through modulation of gut microbiota and suppression of oxidative stress. Int Immunopharmacol 96:107757. https:\/\/doi.org\/10.1016\/j.intimp.2021.107757","journal-title":"Int Immunopharmacol"},{"key":"1561_CR1070","doi-asserted-by":"publisher","unstructured":"El-Derany MO, El-Demerdash E. (2020 Jul) Pyrvinium pamoate attenuates non-alcoholic steatohepatitis: Insight on hedgehog\/Gli and Wnt\/?-catenin signaling crosstalk. Biochem Pharmacol. 177:113942. https:\/\/doi.org\/10.1016\/j.bcp.2020.113942","DOI":"10.1016\/j.bcp.2020.113942"},{"issue":"4","key":"1561_CR30","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/01926230701320337","volume":"35","author":"S Elmore","year":"2007","unstructured":"Elmore S (2007) Apoptosis: a review of programmed cell death. Toxicol Pathol 35(4):495\u2013516","journal-title":"Toxicol Pathol"},{"issue":"5","key":"1561_CR31","doi-asserted-by":"publisher","first-page":"905","DOI":"10.3945\/jn.108.101808","volume":"139","author":"E Esposito","year":"2009","unstructured":"Esposito E, Iacono A, Bianco G, Autore G, Cuzzocrea S, Vajro P, Canani RB, Calignano A, Raso GM, Meli R (2009) Probiotics reduce the inflammatory response induced by a high-fat diet in the liver of young rats. J Nutr 139(5):905\u2013911","journal-title":"J Nutr"},{"issue":"3","key":"1561_CR32","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/mpg.0000000000001422","volume":"64","author":"F Famouri","year":"2017","unstructured":"Famouri F, Shariat Z, Hashemipour M, Keikha M, Kelishadi R (2017) Effects of Probiotics on nonalcoholic fatty liver disease in obese children and adolescents. J Pediatr Gastroenterol Nutr 64(3):413\u2013417. https:\/\/doi.org\/10.1097\/mpg.0000000000001422","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"2","key":"1561_CR33","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s10238-020-00617-4","volume":"20","author":"S Feder","year":"2020","unstructured":"Feder S, Haberl EM, Spirk M, Weiss TS, Wiest R, Buechler C (2020) Pentraxin-3 is not related to disease severity in cirrhosis and hepatocellular carcinoma patients. Clin Exp Med 20(2):289\u2013297. https:\/\/doi.org\/10.1007\/s10238-020-00617-4","journal-title":"Clin Exp Med"},{"key":"1561_CR34","doi-asserted-by":"crossref","unstructured":"Fooladi AAI, Yazdi MH, Pourmand MR, Mirshafiey A, Hassan ZM, Azizi T, Mahdavi M, Dallal MMS (2015) Th1 cytokine production induced by Lactobacillus acidophilus in BALB\/c mice bearing transplanted breast tumor. Jundishapur JMicrobiol 8(4)","DOI":"10.5812\/jjm.8(4)2015.17354"},{"issue":"10","key":"1561_CR35","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1093\/clinchem\/28.10.2077","volume":"28","author":"P Fossati","year":"1982","unstructured":"Fossati P, Prencipe L (1982) Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 28(10):2077\u20132080","journal-title":"Clin Chem"},{"key":"1561_CR36","doi-asserted-by":"crossref","unstructured":"Garcia-Castillo V, Komatsu R, Clua P, Indo Y, Takagi M, Salva S, Islam MA, Alvarez S, Takahashi H, Garcia-Cancino A (2019) Evaluation of the immunomodulatory activities of the probiotic strain Lactobacillus fermentum UCO-979\u00a0C. Front Immunol 10","DOI":"10.3389\/fimmu.2019.01376"},{"key":"1561_CR37","doi-asserted-by":"publisher","first-page":"115101","DOI":"10.1016\/j.taap.2020.115101","volume":"401","author":"SH Gerges","year":"2020","unstructured":"Gerges SH, Wahdan SA, Elsherbiny DA, El-Demerdash E (2020) Diosmin ameliorates inflammation, insulin resistance, and fibrosis in an experimental model of non-alcoholic steatohepatitis in rats. Toxicol Appl Pharmacol 401:115101. https:\/\/doi.org\/10.1016\/j.taap.2020.115101","journal-title":"Toxicol Appl Pharmacol"},{"issue":"3","key":"1561_CR38","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/1574-6941.12137","volume":"85","author":"MP Ginige","year":"2013","unstructured":"Ginige MP, Kaksonen AH, Morris C, Shackelton M, Patterson BM (2013) Bacterial community and groundwater quality changes in an anaerobic aquifer during groundwater recharge with aerobic recycled water. FEMS Microbiol Ecol 85(3):553\u2013567","journal-title":"FEMS Microbiol Ecol"},{"issue":"1","key":"1561_CR39","doi-asserted-by":"publisher","first-page":"16127","DOI":"10.1038\/s41598-018-34633-y","volume":"8","author":"J Henkel","year":"2018","unstructured":"Henkel J, Coleman CD, Schraplau A, J\u00f6hrens K, Weiss TS, Jonas W, Sch\u00fcrmann A, P\u00fcschel GP (2018) Augmented liver inflammation in a microsomal prostaglandin E synthase 1 (mPGES-1)-deficient diet-induced mouse NASH model. Sci Rep 8(1):16127. https:\/\/doi.org\/10.1038\/s41598-018-34633-y","journal-title":"Sci Rep"},{"key":"1561_CR40","first-page":"578","volume-title":"Gut microbiota dysbiosis: triggers, Consequences, Diagnostic and Therapeutic Options","author":"T Hrncir","year":"2022","unstructured":"Hrncir T (2022) Gut microbiota dysbiosis: triggers, Consequences, Diagnostic and Therapeutic Options, vol 10. MDPI, Microorganisms, p 578"},{"issue":"12","key":"1561_CR41","doi-asserted-by":"publisher","first-page":"4423","DOI":"10.1128\/JCM.40.12.4423-4427.2002","volume":"40","author":"XW Huijsdens","year":"2002","unstructured":"Huijsdens XW, Linskens RK, Mak M, Meuwissen SG, Vandenbroucke-Grauls CM, Savelkoul PH (2002) Quantification of bacteria adherent to gastrointestinal mucosa by real-time PCR. J Clin Microbiol 40(12):4423\u20134427","journal-title":"J Clin Microbiol"},{"issue":"6","key":"1561_CR42","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","volume":"22","author":"K Ishak","year":"1995","unstructured":"Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, Desmet V, Korb G, MacSween RN, Phillips MJ, Portman BG, Poulsen H, Schever PJ, Schmid M, a HT (1995) Histological grading and staging of chronic hepatitis. J Hepatol 22(6):696\u2013699. https:\/\/doi.org\/10.1016\/0168-8278(95)80226-6","journal-title":"J Hepatol"},{"issue":"3","key":"1561_CR43","doi-asserted-by":"publisher","first-page":"152","DOI":"10.22336\/rjo.2017.29","volume":"61","author":"C Iulia","year":"2017","unstructured":"Iulia C, Ruxandra T, Costin L-B, Liliana-Mary V (2017) Citicoline\u2013a neuroprotector with proven effects on glaucomatous disease. Rom J Ophthalmol 61(3):152","journal-title":"Rom J Ophthalmol"},{"issue":"1","key":"1561_CR44","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3350\/cmh.2020.0129","volume":"27","author":"E Jennison","year":"2021","unstructured":"Jennison E, Byrne CD (2021) The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease. Clin Mol Hepatol 27(1):22","journal-title":"Clin Mol Hepatol"},{"key":"1561_CR46","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3389\/fmed.2020.00361","volume":"7","author":"X Jiang","year":"2020","unstructured":"Jiang X, Zheng J, Zhang S, Wang B, Wu C, Guo X (2020) Advances in the involvement of Gut Microbiota in Pathophysiology of NAFLD. Front Med 7:361","journal-title":"Front Med"},{"issue":"9","key":"1561_CR45","doi-asserted-by":"publisher","first-page":"3066","DOI":"10.3390\/ijms21093066","volume":"21","author":"Y Ji","year":"2020","unstructured":"Ji Y, Yin Y, Sun L, Zhang W (2020) The molecular and mechanistic insights based on gut\u2013liver axis: nutritional target for non-alcoholic fatty liver disease (NAFLD) improvement. Int J Mol Sci 21(9):3066","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1561_CR47","doi-asserted-by":"publisher","first-page":"e0262767","DOI":"10.1371\/journal.pone.0262767","volume":"17","author":"P Kanmani","year":"2022","unstructured":"Kanmani P, Kim H (2022) Probiotics counteract the expression of hepatic profibrotic genes via the attenuation of TGF-\u03b2\/SMAD signaling and autophagy in hepatic stellate cells. PLoS ONE 17(1):e0262767","journal-title":"PLoS ONE"},{"issue":"1","key":"1561_CR48","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/eat.20658","volume":"43","author":"WDS Killgore","year":"2010","unstructured":"Killgore WDS, Ross AJ, Kamiya T, Kawada Y, Renshaw PF, Yurgelun-Todd DA (2010) Citicoline affects appetite and cortico-limbic responses to images of high-calorie foods. Int J Eat Disord 43(1):6\u201313. https:\/\/doi.org\/10.1002\/eat.20658","journal-title":"Int J Eat Disord"},{"issue":"3","key":"1561_CR49","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.mimet.2010.12.019","volume":"84","author":"MJ Kim","year":"2011","unstructured":"Kim MJ, Hwang KH, Lee Y-S, Park J-Y, Kook J-K (2011) Development of Prevotella intermedia-specific PCR primers based on the nucleotide sequences of a DNA probe Pig27. J Microbiol Methods 84(3):394\u2013397","journal-title":"J Microbiol Methods"},{"key":"1561_CR50","doi-asserted-by":"crossref","unstructured":"Kobyliak N, Abenavoli L, Mykhalchyshyn G, Kononenko L, Boccuto L, Kyriienko D, Dynnyk O (2018) A multi-strain probiotic reduces the fatty liver index, cytokines and aminotransferase levels in NAFLD patients: evidence from a randomized clinical trial. J Gastrointestin Liver Dis","DOI":"10.15403\/jgld.2014.1121.271.kby"},{"issue":"5","key":"1561_CR51","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1136\/jcp.54.5.356","volume":"54","author":"D Koracevic","year":"2001","unstructured":"Koracevic D, Koracevic G, Djordjevic V, Andrejevic S, Cosic V (2001) Method for the measurement of antioxidant activity in human fluids. J Clin Pathol 54(5):356\u2013361. https:\/\/doi.org\/10.1136\/jcp.54.5.356","journal-title":"J Clin Pathol"},{"issue":"7122","key":"1561_CR52","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/4441022a","volume":"444","author":"RE Ley","year":"2006","unstructured":"Ley RE, Turnbaugh PJ, Klein S, Gordon JI (2006) Microbial ecology: human gut microbes associated with obesity. Nature 444(7122):1022\u20131023. https:\/\/doi.org\/10.1038\/4441022a","journal-title":"Nature"},{"key":"1561_CR54","doi-asserted-by":"crossref","unstructured":"Liu Y, Huang W, Wang J, Ma J, Zhang M, Lu X, Liu J, Kou Y (2021) Multifaceted impacts of Periodontal Pathogens in Disorders of the intestinal barrier. Front Immunol:3010","DOI":"10.3389\/fimmu.2021.693479"},{"issue":"2","key":"1561_CR53","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1053\/jhep.2003.50048","volume":"37","author":"Z Li","year":"2003","unstructured":"Li Z, Yang S, Lin H, Huang J, Watkins PA, Moser AB, DeSimone C, Song Xy, Diehl AM (2003) Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology (Baltimore MD) 37(2):343\u2013350","journal-title":"Hepatology (Baltimore MD)"},{"issue":"5","key":"1561_CR55","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/clinchem\/23.5.882","volume":"23","author":"MF Lopes-Virella","year":"1977","unstructured":"Lopes-Virella MF, Stone P, Ellis S, Colwell JA (1977) Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem 23(5):882\u2013884","journal-title":"Clin Chem"},{"issue":"4","key":"1561_CR60","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/S1665-2681(19)31457-7","volume":"11","author":"MV Machado","year":"2012","unstructured":"Machado MV, Cortez-Pinto H (2012) Gut microbiota and nonalcoholic fatty liver disease. Ann Hepatol 11(4):440\u2013449","journal-title":"Ann Hepatol"},{"issue":"1","key":"1561_CR61","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/00365520701559003","volume":"43","author":"MV Machado","year":"2008","unstructured":"Machado MV, Ravasco P, Jesus L, Marques-Vidal P, Oliveira CR, Proen\u00e7a T, Baldeiras I, Camilo ME, Cortez-Pinto H (2008) Blood oxidative stress markers in non-alcoholic steatohepatitis and how it correlates with diet. Scand J Gastroenterol 43(1):95\u2013102. https:\/\/doi.org\/10.1080\/00365520701559003","journal-title":"Scand J Gastroenterol"},{"issue":"12","key":"1561_CR62","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.1016\/j.watres.2009.04.017","volume":"43","author":"AF Maheux","year":"2009","unstructured":"Maheux AF, Picard FJ, Boissinot M, Bissonnette L, Paradis S, Bergeron MG (2009) Analytical comparison of nine PCR primer sets designed to detect the presence of Escherichia coli\/Shigella in water samples. Water Res 43(12):3019\u20133028","journal-title":"Water Res"},{"key":"1561_CR57","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1146\/annurev-pharmtox-011112-140320","volume":"53","author":"Q Ma","year":"2013","unstructured":"Ma Q (2013) Role of nrf2 in oxidative stress and toxicity. Annu Rev Pharmacol Toxicol 53:401\u2013426. https:\/\/doi.org\/10.1146\/annurev-pharmtox-011112-140320","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"1\u20132","key":"1561_CR63","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0027-5107(85)90216-7","volume":"148","author":"SL Marklund","year":"1985","unstructured":"Marklund SL (1985) Superoxide dismutase isoenzymes in tissues and plasma from New Zealand black mice, nude mice and normal BALB\/c mice. Mutat Res 148(1\u20132):129\u2013134. https:\/\/doi.org\/10.1016\/0027-5107(85)90216-7","journal-title":"Mutat Res"},{"key":"1561_CR64","doi-asserted-by":"publisher","DOI":"10.4274\/tjps.galenos.2021.51882","author":"F Masoud","year":"2021","unstructured":"Masoud F, Habibi-Asl B, Charkhpour M, Asadpour Y, Mahmoudi J (2021) Dexamethasone and citicoline mitigate cisplatin-induced peripheral neuropathy: a novel experimental study in mice. Turk J Pharm Sci. https:\/\/doi.org\/10.4274\/tjps.galenos.2021.51882","journal-title":"Turk J Pharm Sci"},{"issue":"11","key":"1561_CR65","doi-asserted-by":"publisher","first-page":"5445","DOI":"10.1128\/AEM.68.11.5445-5451.2002","volume":"68","author":"T Matsuki","year":"2002","unstructured":"Matsuki T, Watanabe K, Fujimoto J, Miyamoto Y, Takada T, Matsumoto K, Oyaizu H, Tanaka R (2002) Development of 16S rRNA-gene-targeted group-specific primers for the detection and identification of predominant bacteria in human feces. Appl Environ Microbiol 68(11):5445\u20135451","journal-title":"Appl Environ Microbiol"},{"issue":"5","key":"1561_CR58","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.jhep.2008.05.025","volume":"49","author":"X Ma","year":"2008","unstructured":"Ma X, Hua J, Li Z (2008) Probiotics improve high fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells. J Hepatol 49(5):821\u2013830","journal-title":"J Hepatol"},{"issue":"40","key":"1561_CR59","doi-asserted-by":"publisher","first-page":"6911","DOI":"10.3748\/wjg.v19.i40.6911","volume":"19","author":"Y-Y Ma","year":"2013","unstructured":"Ma Y-Y, Li L, Yu C-H, Shen Z, Chen L-H, Li Y-M (2013) Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis. World J Gastroenterol 19(40):6911","journal-title":"World J Gastroenterol"},{"issue":"Suppl 1","key":"1561_CR66","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1159\/000447275","volume":"34","author":"A Mazzotti","year":"2016","unstructured":"Mazzotti A, Caletti MT, Sasdelli AS, Brodosi L, Marchesini GJDD (2016) Pathophysiology of nonalcoholic fatty liver disease: lifestyle-gut-gene interaction. Dig Dis 34(Suppl 1):3\u201310","journal-title":"Dig Dis"},{"issue":"6","key":"1561_CR67","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.cmet.2015.09.023","volume":"22","author":"C Meex Ruth","year":"2015","unstructured":"Meex Ruth C, Hoy Andrew J, Morris A, Brown Russell D, Lo Jennifer CY, Burke M, Goode Robert JA, Kingwell Bronwyn A, Kraakman Michael J, Febbraio Mark A, Greve Jan W, Rensen Sander S, Molloy Mark P, Lancaster Graeme I, Bruce Clinton R, Watt Matthew J (2015) Fetuin B is a secreted hepatocyte factor linking steatosis to impaired glucose metabolism. Cell Metab 22(6):1078\u20131089. https:\/\/doi.org\/10.1016\/j.cmet.2015.09.023","journal-title":"Cell Metab"},{"issue":"2","key":"1561_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/femsec\/fiu002","volume":"91","author":"S Michail","year":"2015","unstructured":"Michail S, Lin M, Frey MR, Fanter R, Paliy O, Hilbush B, Reo NVJFme (2015) Altered gut microbial energy and metabolism in children with non-alcoholic fatty liver disease. FEMS Microbiol Ecol 91(2):1","journal-title":"FEMS Microbiol Ecol"},{"issue":"9","key":"1561_CR69","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/j.cellsig.2011.05.013","volume":"23","author":"KJ Min","year":"2011","unstructured":"Min KJ, Lee JT, Joe EH, Kwon TK (2011) An I\u03baB\u03b1 phosphorylation inhibitor induces heme oxygenase-1(HO-1) expression through the activation of reactive oxygen species (ROS)-Nrf2-ARE signaling and ROS-PI3K\/Akt signaling in an NF-\u03baB-independent mechanism. Cell Signal 23(9):1505\u20131513. https:\/\/doi.org\/10.1016\/j.cellsig.2011.05.013","journal-title":"Cell Signal"},{"issue":"6","key":"1561_CR70","first-page":"1077","volume":"64","author":"H Mitsuyoshi","year":"2006","unstructured":"Mitsuyoshi H, Itoh Y, Okanoue T (2006) [Role of oxidative stress in non-alcoholic steatohepatitis]. Nihon Rinsho 64(6):1077\u20131082","journal-title":"Nihon Rinsho"},{"issue":"2","key":"1561_CR71","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3945\/an.116.013151","volume":"8","author":"Z Mokhtari","year":"2017","unstructured":"Mokhtari Z, Gibson DL, Hekmatdoost A (2017) Nonalcoholic fatty liver disease, the gut microbiome, and diet. Adv Nutr 8(2):240\u2013252","journal-title":"Adv Nutr"},{"issue":"4","key":"1561_CR72","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nrd.2015.3","volume":"15","author":"G Musso","year":"2016","unstructured":"Musso G, Cassader M, Gambino R (2016) Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies. Nat Rev Drug Discov 15(4):249\u2013274. https:\/\/doi.org\/10.1038\/nrd.2015.3","journal-title":"Nat Rev Drug Discov"},{"issue":"15","key":"1561_CR73","doi-asserted-by":"publisher","first-page":"8008","DOI":"10.3390\/ijms22158008","volume":"22","author":"M Nagashimada","year":"2021","unstructured":"Nagashimada M, Honda M (2021) Effect of Microbiome on non-alcoholic fatty liver Disease and the role of Probiotics, Prebiotics, and Biogenics. Int J Mol Sci 22(15):8008","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1561_CR74","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s00535-017-1368-4","volume":"53","author":"T Nakahara","year":"2018","unstructured":"Nakahara T, Hyogo H, Ono A, Nagaoki Y, Kawaoka T, Miki D, Tsuge M, Hiraga N, Hayes CN, Hiramatsu A (2018) Involvement of Porphyromonas gingivalis in the progression of non-alcoholic fatty liver disease. J Gastroenterol 53(2):269\u2013280","journal-title":"J Gastroenterol"},{"issue":"7","key":"1561_CR75","doi-asserted-by":"publisher","first-page":"e0134234","DOI":"10.1371\/journal.pone.0134234","volume":"10","author":"M Nakajima","year":"2015","unstructured":"Nakajima M, Arimatsu K, Kato T, Matsuda Y, Minagawa T, Takahashi N, Ohno H, Yamazaki K (2015) Oral administration of P. gingivalis induces dysbiosis of gut microbiota and impaired barrier function leading to dissemination of enterobacteria to the liver. PLoS ONE 10(7):e0134234","journal-title":"PLoS ONE"},{"issue":"3","key":"1561_CR76","doi-asserted-by":"publisher","first-page":"G669","DOI":"10.1152\/ajpgi.00188.2010","volume":"299","author":"G Nardone","year":"2010","unstructured":"Nardone G, Compare D, Liguori E, Di Mauro V, Rocco A, Barone M, Napoli A, Lapi D, Iovene MR, Colantuoni A (2010) Protective effects of Lactobacillus paracasei F19 in a rat model of oxidative and metabolic hepatic injury. Am J Physiol Gastrointest Liver Physiol 299(3):G669\u2013G676","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"11","key":"1561_CR78","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1155\/2014\/757929","volume":"28","author":"MG Neuman","year":"2014","unstructured":"Neuman MG, Cohen LB, Nanau RM (2014) Biomarkers in nonalcoholic fatty liver disease. Can J Gastroenterol Hepatol 28(11):607\u2013618. https:\/\/doi.org\/10.1155\/2014\/757929","journal-title":"Can J Gastroenterol Hepatol"},{"key":"1561_CR77","doi-asserted-by":"publisher","first-page":"429805","DOI":"10.1155\/2012\/429805","volume":"2012","author":"M Neuman","year":"2012","unstructured":"Neuman M, Hilzenrat N, Cohen L, Winkler RE, Nanau R (2012) Multiple factors involved in nonalcoholic hepatitis pathogenesis. Int J Hepatol 2012:429805. https:\/\/doi.org\/10.1155\/2012\/429805","journal-title":"Int J Hepatol"},{"issue":"5","key":"1561_CR79","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1093\/qjmed\/hcz283","volume":"113","author":"WB Nseir","year":"2020","unstructured":"Nseir WB, Hussein SHH, Farah R, Mahamid MN, Khatib HH, Mograbi JM, Peretz A, Amara AE (2020) Nonalcoholic fatty liver disease as a risk factor for Clostridium difficile-associated diarrhea. QJM: monthly journal of the Association of Physicians 113(5):320\u2013323. https:\/\/doi.org\/10.1093\/qjmed\/hcz283","journal-title":"QJM: monthly journal of the Association of Physicians"},{"issue":"2","key":"1561_CR80","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","volume":"95","author":"H Ohkawa","year":"1979","unstructured":"Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95(2):351\u2013358. https:\/\/doi.org\/10.1016\/0003-2697(79)90738-3","journal-title":"Anal Biochem"},{"issue":"5","key":"1561_CR81","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1007\/s00535-012-0659-z","volume":"48","author":"K Okada","year":"2013","unstructured":"Okada K, Warabi E, Sugimoto H, Horie M, Gotoh N, Tokushige K, Hashimoto E, Utsunomiya H, Takahashi H, Ishii T, Yamamoto M, Shoda J (2013) Deletion of Nrf2 leads to rapid progression of steatohepatitis in mice fed atherogenic plus high-fat diet. J Gastroenterol 48(5):620\u2013632. https:\/\/doi.org\/10.1007\/s00535-012-0659-z","journal-title":"J Gastroenterol"},{"issue":"1","key":"1561_CR82","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/2050-7771-1-7","volume":"1","author":"SG Pearce","year":"2013","unstructured":"Pearce SG, Thosani NC, Pan JJ (2013) Noninvasive biomarkers for the diagnosis of steatohepatitis and advanced fibrosis in NAFLD. Biomark Res 1(1):7. https:\/\/doi.org\/10.1186\/2050-7771-1-7","journal-title":"Biomark Res"},{"issue":"1","key":"1561_CR83","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s12291-014-0446-0","volume":"30","author":"A Phaniendra","year":"2015","unstructured":"Phaniendra A, Jestadi DB, Periyasamy L (2015) Free radicals: properties, sources, targets, and their implication in various diseases. Indian J Clin biochemistry: IJCB 30(1):11\u201326. https:\/\/doi.org\/10.1007\/s12291-014-0446-0","journal-title":"Indian J Clin biochemistry: IJCB"},{"issue":"1","key":"1561_CR84","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.numecd.2019.10.001","volume":"30","author":"B Pourrajab","year":"2020","unstructured":"Pourrajab B, Fatahi S, Dehnad A, Varkaneh HK, Shidfar F (2020) The impact of probiotic yogurt consumption on lipid profiles in subjects with mild to moderate hypercholesterolemia: a systematic review and meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis 30(1):11\u201322","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"1","key":"1561_CR85","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/hep.23276","volume":"51","author":"K Promrat","year":"2010","unstructured":"Promrat K, Kleiner DE, Niemeier HM, Jackvony E, Kearns M, Wands JR, Fava JL, Wing RR (2010) Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology (Baltimore MD) 51(1):121\u2013129. https:\/\/doi.org\/10.1002\/hep.23276","journal-title":"Hepatology (Baltimore MD)"},{"issue":"7","key":"1561_CR86","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1007\/s11064-014-1299-x","volume":"39","author":"K Qian","year":"2014","unstructured":"Qian K, Gu Y, Zhao Y, Li Z, Sun M (2014) Citicoline protects brain against closed Head Injury in rats through suppressing oxidative stress and calpain over-activation. Neurochem Res 39(7):1206\u20131218. https:\/\/doi.org\/10.1007\/s11064-014-1299-x","journal-title":"Neurochem Res"},{"issue":"1","key":"1561_CR87","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/microorganisms7010014","volume":"7","author":"E Rinninella","year":"2019","unstructured":"Rinninella E, Raoul P, Cintoni M, Franceschi F, Miggiano GAD, Gasbarrini A, Mele MC (2019) What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases. Microorganisms 7(1):14","journal-title":"Microorganisms"},{"issue":"2","key":"1561_CR88","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.jocn.2009.05.016","volume":"17","author":"S Sahin","year":"2010","unstructured":"Sahin S, Alkan T, Temel SG, Tureyen K, Tolunay S, Korfali E (2010) Effects of citicoline used alone and in combination with mild hypothermia on apoptosis induced by focal cerebral ischemia in rats. J Clin Neurosci 17(2):227\u2013231. https:\/\/doi.org\/10.1016\/j.jocn.2009.05.016","journal-title":"J Clin Neurosci"},{"key":"1561_CR89","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3389\/fmicb.2018.00061","volume":"9","author":"ET Saltzman","year":"2018","unstructured":"Saltzman ET, Palacios T, Thomsen M, Vitetta L (2018) Intestinal microbiome shifts, dysbiosis, inflammation, and non-alcoholic fatty liver disease. Front Microbiol 9:61","journal-title":"Front Microbiol"},{"key":"1561_CR90","doi-asserted-by":"publisher","first-page":"634","DOI":"10.5137\/1019-5149.JTN.6008-12.0","volume":"22","author":"M Savran","year":"2012","unstructured":"Savran M, Bekar A, Cansev M, Tolunay S, Ulus I, Ta\u015fkap\u0131l\u0131o\u011flu M (2012) Prevention of Epidural Fibrosis in rats by local or systemic administration of Citicoline. Turk Neurosurg 22:634\u2013640. https:\/\/doi.org\/10.5137\/1019-5149.JTN.6008-12.0","journal-title":"Turk Neurosurg"},{"issue":"3","key":"1561_CR91","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.jcmgh.2017.11.016","volume":"5","author":"RS Sharma","year":"2018","unstructured":"Sharma RS, Harrison DJ, Kisielewski D, Cassidy DM, McNeilly AD, Gallagher JR, Walsh SV, Honda T, McCrimmon RJ, Dinkova-Kostova AT, Ashford MLJ, Dillon JF, Hayes JD (2018) Experimental nonalcoholic steatohepatitis and liver fibrosis are ameliorated by pharmacologic activation of Nrf2 (NF-E2 p45-Related factor 2). Cell Mol Gastroenterol Hepatol 5(3):367\u2013398. https:\/\/doi.org\/10.1016\/j.jcmgh.2017.11.016","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"1","key":"1561_CR92","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/ajcn\/nqz042","volume":"110","author":"SR Sharpton","year":"2019","unstructured":"Sharpton SR, Maraj B, Harding-Theobald E, Vittinghoff E, Terrault NA (2019) Gut microbiome\u2013targeted therapies in nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression. Am J Clin Nutr 110(1):139\u2013149","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"1561_CR93","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S1499-3872(17)60019-5","volume":"16","author":"F Shen","year":"2017","unstructured":"Shen F, Zheng R-D, Sun X-Q, Ding W-J, Wang X-Y, Fan J-G (2017) Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease. Hepatobiliary Pancreat Dis Int 16(4):375\u2013381","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"1561_CR94","doi-asserted-by":"publisher","unstructured":"Synoradzki K, Grieb P (2019) Citicoline: a Superior form of Choline? Nutrients 11(7). https:\/\/doi.org\/10.3390\/nu11071569","DOI":"10.3390\/nu11071569"},{"issue":"3","key":"1561_CR95","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1002\/hep.22711","volume":"49","author":"A Velayudham","year":"2009","unstructured":"Velayudham A, Dolganiuc A, Ellis M, Petrasek J, Kodys K, Mandrekar P, Szabo G (2009) VSL# 3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice. Hepatology (Baltimore MD) 49(3):989\u2013997","journal-title":"Hepatology (Baltimore MD)"},{"issue":"3","key":"1561_CR96","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","volume":"34","author":"G Vernon","year":"2011","unstructured":"Vernon G, Baranova A, Younossi Z (2011) Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non\u2010alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 34(3):274\u2013285","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"1561_CR97","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1093\/jn\/138.10.1866","volume":"138","author":"Y Wang","year":"2008","unstructured":"Wang Y, Ausman LM, Russell RM, Greenberg AS, Wang XD (2008) Increased apoptosis in high-fat diet-induced nonalcoholic steatohepatitis in rats is associated with c-Jun NH2-terminal kinase activation and elevated proapoptotic bax. J Nutr 138(10):1866\u20131871. https:\/\/doi.org\/10.1093\/jn\/138.10.1866","journal-title":"J Nutr"},{"issue":"2","key":"1561_CR98","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00253-009-2012-x","volume":"84","author":"Y Wang","year":"2009","unstructured":"Wang Y, Xu N, Xi A, Ahmed Z, Zhang B, Bai X (2009) Effects of Lactobacillus plantarum MA2 isolated from Tibet kefir on lipid metabolism and intestinal microflora of rats fed on high-cholesterol diet. Appl Microbiol Biotechnol 84(2):341\u2013347","journal-title":"Appl Microbiol Biotechnol"},{"issue":"1","key":"1561_CR99","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/hep.21223","volume":"44","author":"A Wieckowska","year":"2006","unstructured":"Wieckowska A, Zein NN, Yerian LM, Lopez AR, McCullough AJ, Feldstein AE (2006) In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease. Hepatology (Baltimore MD) 44(1):27\u201333. https:\/\/doi.org\/10.1002\/hep.21223","journal-title":"Hepatology (Baltimore MD)"},{"issue":"8","key":"1561_CR100","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1136\/gutjnl-2016-312766","volume":"66","author":"SH Wong","year":"2017","unstructured":"Wong SH, Kwong TN, Chow T-C, Luk AK, Dai RZ, Nakatsu G, Lam TY, Zhang L, Wu JC, Chan FK (2017) Quantitation of faecal Fusobacterium improves faecal immunochemical test in detecting advanced colorectal neoplasia. Gut 66(8):1441\u20131448","journal-title":"Gut"},{"issue":"1","key":"1561_CR102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-016-0028-x","volume":"7","author":"L Xue","year":"2017","unstructured":"Xue L, He J, Gao N, Lu X, Li M, Wu X, Liu Z, Jin Y, Liu J, Xu J (2017) Probiotics may delay the progression of nonalcoholic fatty liver disease by restoring the gut microbiota structure and improving intestinal endotoxemia. Sci Rep 7(1):1\u201313","journal-title":"Sci Rep"},{"key":"1561_CR101","doi-asserted-by":"crossref","unstructured":"Xu R-y, Wan Y-p, Fang Q-y, Lu W, Cai W (2011) Supplementation with probiotics modifies gut flora and attenuates liver fat accumulation in rat nonalcoholic fatty liver disease model. J Clin Biochem Nutr: 1108190104\u20131108190104","DOI":"10.3164\/jcbn.11-38"},{"key":"1561_CR103","doi-asserted-by":"publisher","first-page":"327","DOI":"10.5152\/tjg.2017.030817","volume":"28","author":"Y Yilmaz","year":"2017","unstructured":"Yilmaz Y, Eren F (2017) Nonalcoholic steatohepatitis and gut microbiota: future perspectives on probiotics in metabolic liver diseases. Turk J Gastroenterol 28:327\u2013328","journal-title":"Turk J Gastroenterol"},{"issue":"1","key":"1561_CR104","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M (2016) Global epidemiology of nonalcoholic fatty liver disease\u2014meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology (Baltimore MD) 64(1):73\u201384","journal-title":"Hepatology (Baltimore MD)"},{"issue":"1","key":"1561_CR105","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jhep.2015.09.005","volume":"64","author":"X Zhang","year":"2016","unstructured":"Zhang X, Han J, Man K, Li X, Du J, Chu ES, Go MY, Sung JJ, Yu J (2016) CXC chemokine receptor 3 promotes steatohepatitis in mice through mediating inflammatory cytokines, macrophages and autophagy. J Hepatol 64(1):160\u2013170. https:\/\/doi.org\/10.1016\/j.jhep.2015.09.005","journal-title":"J Hepatol"},{"issue":"1","key":"1561_CR106","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1007\/s12020-016-1112-5","volume":"56","author":"J Zhu","year":"2017","unstructured":"Zhu J, Wan X, Wang Y, Zhu K, Li C, Yu C, Li Y (2017) Serum fetuin B level increased in subjects of nonalcoholic fatty liver disease: a case-control study. Endocrine 56(1):208\u2013211. https:\/\/doi.org\/10.1007\/s12020-016-1112-5","journal-title":"Endocrine"},{"issue":"2","key":"1561_CR107","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/hep.26093","volume":"57","author":"L Zhu","year":"2013","unstructured":"Zhu L, Baker SS, Gill C, Liu W, Alkhouri R, Baker RD, Gill SR (2013) Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH. Hepatology (Baltimore MD) 57(2):601\u2013609","journal-title":"Hepatology (Baltimore MD)"}],"container-title":["AMB Express"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13568-023-01561-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13568-023-01561-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13568-023-01561-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T17:02:32Z","timestamp":1686243752000},"score":1,"resource":{"primary":{"URL":"https:\/\/amb-express.springeropen.com\/articles\/10.1186\/s13568-023-01561-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,8]]},"references-count":107,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1561"],"URL":"https:\/\/doi.org\/10.1186\/s13568-023-01561-8","relation":{},"ISSN":["2191-0855"],"issn-type":[{"value":"2191-0855","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,8]]},"assertion":[{"value":"15 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The experimental protocol was permitted by Research Ethics Committee, Faculty of Pharmacy, Delta University for Science and Technology (ethical approval number: FPDU6\/2022).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"57"}}